Moraxella catarrhalis in acute laryngitis: Infection or colonization?

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 636-638

  Hol, C ^b   Schalen C ^b   Verduin, C M ^b   Van Dijke, E E M ^b   Verhoef, J ^b   Fleer, A ^b   Van Dijk, H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CHILD; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATION PROCEDURE; LARYNGITIS; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0029781691     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.636     Document Type: Article

References (15)

1. Schalén L, Christensen P, Eliasson I, Fex S, Kamme C, Schalén C. Inefficacy of penicillin V in acute laryngitis in adults. Ann Otol Rhinol Laryngol 1985;94:14-7.
2. Vaughan CW. Diagnosis and treatment of organic voice disorders. N Engl J Med 1982;307:863-6.
3. Schalén L, Christensen P, Kamme C, Miörner H, Pettersson KI, Schalen C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis 1980;12:277-80.
4. Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van den Abeele A. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990;28:2674-80.
5. Ejlertsen T. Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults [letter]. Eur J Clin Microbiol Infect Dis 1991; 10:89.
6. Hol C, Verduin CM, Van Dijke E, Verhoef J, Van Dijk H. Complement resistance in Branhamella (Moraxella) catarrhalis [letter]. Lancet 1993; 341:1281.
7. Verduin CM, Hoi C, Bootsma HJ, Verhoef J, Van Dijk H. Observations on constitutional resistance to infection. Immunol Today 1993; 14:44-5.
8. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
9. Hol C, Verduin CM, Van Dijke EEM, Verhoef J, Van Dijk II. Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis. FEMS Immunol Med Microbiol 1995;11:207-12.
10. Verduin CM, Hoi C, Van Dijke E, et al. Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol 1995;2:365-8.
11. Verduin CM, Jansze M, Hol C, Mollness TE, Verhoef J, Van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun 1994;62:589-95.
12. Verduin CM, Hoi C, Jansze M, Van Dijke EEM, Van Dijk H. Complement resistance in Moraxella (Branhamella) catarrhalis is species-restricted and mediated by the binding of human vitronectin. In: Verduin CM, Watson DA, Van Dijk H, Verhoef J, eds. Constitutional resistance to infection. Georgetown, TX: RG Landes, 1995: 25-35.
13. Chhatwal GS, Preissner KT, Müller-Bergbaus G, Blobed H. Specific binding of the human S protein (vitronectin) to streptococci, Staphy-lococcus aureus, and Escherichia coli. Infect Immun 1987;55: 1878-83.
14. Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol 1991;7:275-310.
15. Schalen L, Eliasson I, Kamme C, Schalén C. Erythromycin in acute laryngitis in adults. Ann Otol Rhinol Laryngol 1993;102:209-14.